Cargando…

Transitions and touchpoints in idiopathic pulmonary fibrosis

Patients with idiopathic pulmonary fibrosis (IPF) face a poor prognosis and endure intrusive symptoms that impair quality of life. Many patients with IPF will require supplemental oxygen (O(2)) at some point in the course of their illness, and although it can improve blood oxygen and symptoms, O(2)...

Descripción completa

Detalles Bibliográficos
Autor principal:	Swigris, Jeffrey J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045697/ https://www.ncbi.nlm.nih.gov/pubmed/30018766 http://dx.doi.org/10.1136/bmjresp-2018-000317

Ejemplares similares

A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives
por: Swigris, Jeffrey J, et al.
Publicado: (2005)

Designing satisfying service encounters: website versus store touchpoints
por: Bolton, Ruth N., et al.
Publicado: (2021)

Interventions for child development based on the Touchpoints Model: scoping review
por: Vicente, Jéssica Batistela, et al.
Publicado: (2023)

TouchPoints: Creating Powerful Leadership Connections in the Smallest of Moments
por: Norgaard, Mette
Publicado: (2011)

Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis
por: Olson, Amy L, et al.
Publicado: (2016)

Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study
por: Raimundo, Karina, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers
por: Ramadurai, Deepa, et al.
Publicado: (2019)

Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis
por: Guo, Mengqin, et al.
Publicado: (2023)

The psychometric properties of the St George’s Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review
por: Swigris, Jeffrey J, et al.
Publicado: (2014)

The need for patient-centred clinical research in idiopathic pulmonary fibrosis
por: Russell, Anne-Marie, et al.
Publicado: (2015)

Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire
por: Swigris, Jeffrey J., et al.
Publicado: (2020)

Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Cao, Mengshu, et al.
Publicado: (2016)

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?
por: Aronson, Kerri, et al.
Publicado: (2023)

Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials
por: Swigris, Jeffrey J, et al.
Publicado: (2018)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Salton, Francesco, et al.
Publicado: (2019)

Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease
por: Pan, Rui-Li, et al.
Publicado: (2018)

Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)
por: Yorke, Janelle, et al.
Publicado: (2014)

Introducing the trajectory Touchpoint technique: a systematic methodology for capturing the service experiences of palliative care patients and their families
por: Sudbury-Riley, Lynn, et al.
Publicado: (2020)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

Iron metabolism regulation of epithelial-mesenchymal transition in idiopathic pulmonary fibrosis
por: Han, Yi, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)
por: Xu, Feng, et al.
Publicado: (2021)

The never-ending patient journey of chronically ill patients: A qualitative case study on touchpoints in relation to patient-centered care
por: Maas, Vera K., et al.
Publicado: (2023)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis
por: Gaikwad, Archana Vijay, et al.
Publicado: (2023)

Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment
por: Bromberg, Daniel J., et al.
Publicado: (2023)

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
por: Noble, Paul W., et al.
Publicado: (2016)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4c1peh41i8l15jt99pep4emem